SUZHOU, China, June 1, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced completion of first patient dosing in PET-CT...
from PR Newswire: https://ift.tt/3wOIBhx
No comments:
Post a Comment